Gynura procumbens Reverses Acute and Chronic Ethanol-Induced Liver Steatosis through MAPK/SREBP-1c-Dependent and -Independent Pathways

Journal of Agricultural and Food Chemistry

Volumn 63, Issue 38, 2015, Pages 8460-8471

  Li, Xiao Jun ^a   Mu, Yun Mei ^a   Li, Ting Ting ^a   Yang, Yan Ling ^a   Zhang, Mei Tuo ^a   Li, Yu Sang ^a   Zhang, Wei Kevin ^a   Tang, He Bin ^a,b   Shang, Hong Cai ^b  

^a SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

alcoholic liver disease; chlorogenic acid; Gynura procumbens; MAPK; SREBP 1c; steatosis

Indexed keywords

AMINO ACIDS;

CHLOROGENIC ACIDS; GYNURA PROCUMBENS; LIVER DISEASE; MAPK; STEATOSIS;

ETHANOL;

ALCOHOL; MITOGEN ACTIVATED PROTEIN KINASE KINASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ACUTE DISEASE; ANIMAL; CHEMICALLY INDUCED; CHRONIC DISEASE; DISEASE MODEL; FATTY LIVER; GENETICS; HUMAN; MALE; METABOLISM; SIGNAL TRANSDUCTION;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ETHANOL; FATTY LIVER; HUMANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84942626384     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/acs.jafc.5b03504     Document Type: Article

References (43)

1. Louvet, A.; Mathurin, P. Alcoholic liver disease: mechanisms of injury and targeted treatment Nat. Rev. Gastroenterol. Hepatol. 2015, 12, 231-42 10.1038/nrgastro.2015.35
2. Testino, G.; Leone, S.; Ansaldi, F.; Borro, P. Silymarin and S-adenosyl-L-methionine (SAMe): two promising pharmacological agents in case of chronic alcoholic hepathopathy. A review and a point of view Minerva Gastroenterol. Dietol. 2013, 59, 341-56
3. Xiao, S. J.; Fu, G. J.; Lv, Y. L.; Zhong, X. N.; Wang, R. H. Prevalence and risk factors of fatty liver disease in young and middle-aged population: one center study in Southwestern China J. Gastroenterol. Hepatol. 2014, 29, 358-64 10.1111/jgh.12334
4. O'Shea, R. S.; Dasarathy, S.; McCullough, A. J. Alcoholic liver disease Am. J. Gastroenterol. 2010, 105, 14-32 (quiz 33) 10.1038/ajg.2009.593
5. Ding, R. B.; Tian, K.; Cao, Y. W.; Bao, J. L.; Wang, M.; He, C.; Hu, Y.; Su, H.; Wan, J. B. Protective effect of panax notoginseng saponins on acute ethanol-induced liver injury is associated with ameliorating hepatic lipid accumulation and reducing ethanol-mediated oxidative stress J. Agric. Food Chem. 2015, 63, 2413-22 10.1021/jf502990n
6. Algariri, K.; Meng, K. Y.; Atangwho, I. J.; Asmawi, M. Z.; Sadikun, A.; Murugaiyah, V.; Ismail, N. Hypoglycemic and anti-hyperglycemic study of Gynura procumbens leaf extracts Asian Pac. J. Trop. Biomed. 2013, 3, 358-66 10.1016/S2221-1691(13)60077-5
7. Nisa, F.; Hermawan, A.; Murwanti, R.; Meiyanto, E. Antiproliferative effect of gynura procumbens (lour.) Merr. Leaves etanolic extract on 7,12-dimethylbenz(a)antracene induced male rat liver Adv. Pharm. Bull. 2012, 2, 99-106 10.5681/apb.2012.014
8. Shwter, A. N.; Abdullah, N. A.; Alshawsh, M. A.; Alsalahi, A.; Hajrezaei, M.; Almaqrami, A. A.; Salem, S. D.; Abdulla, M. A. Chemoprevention of colonic aberrant crypt foci by Gynura procumbens in rats J. Ethnopharmacol. 2014, 151, 1194-201 10.1016/j.jep.2013.12.044
9. Mahmood, A. A.; Mariod, A. A.; Al-Bayaty, F.; Abdel-Wahab, S. I. Anti-ulcerogenic activity of Gynura procumbens leaf extract against experimentally-induced gastric lesions in rats J. Med. Plant Res. 2010, 4, 685-91 10.5897/JMPR10.018
10. Kim, C. W.; Moon, Y. A.; Park, S. W.; Cheng, D.; Kwon, H. J.; Horton, J. D. Induced polymerization of mammalian acetyl-CoA carboxylase by MIG12 provides a tertiary level of regulation of fatty acid synthesis Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 9626-31 10.1073/pnas.1001292107
11. Shimano, H. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes Prog. Lipid Res. 2001, 40, 439-52 10.1016/S0163-7827(01)00010-8
12. Horton, J. D.; Goldstein, J. L.; Brown, M. S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver J. Clin. Invest. 2002, 109, 1125-31 10.1172/JCI0215593
13. Li, Y.; Xu, S. Q.; Mihaylova, M. M.; Zheng, B.; Hou, X. Y.; Jiang, B. B.; Park, O.; Luo, Z. J.; Lefai, E.; Shyy, J. Y. J.; Gao, B.; Wierzbicki, M.; Verbeuren, T. J.; Shaw, R. J.; Cohen, R. A.; Zang, M. W. AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice Cell Metab. 2011, 13, 376-388 10.1016/j.cmet.2011.03.009
14. Hong-Brown, L. Q.; Brown, C. R.; Huber, D. S.; Lang, C. H. Alcohol and indinavir adversely affect protein synthesis and phosphorylation of MAPK and mTOR signaling pathways in C2C12 myocytes Alcohol.: Clin. Exp. Res. 2006, 30, 1297-307 10.1111/j.1530-0277.2006.00157.x
15. Knebel, B.; Lehr, S.; Hartwig, S.; Haas, J.; Kaber, G.; Dicken, H. D.; Susanto, F.; Bohne, L.; Jacob, S.; Nitzgen, U.; Passlack, W.; Muller-Wieland, D.; Kotzka, J. Phosphorylation of sterol regulatory element-binding protein (SREBP)-1c by p38 kinases, ERK and JNK influences lipid metabolism and the secretome of human liver cell line HepG2 Arch. Physiol. Biochem. 2014, 120, 216-27 10.3109/13813455.2014.973418
16. Ji, C.; Chan, C.; Kaplowitz, N. Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model J. Hepatol. 2006, 45, 717-24 10.1016/j.jhep.2006.05.009
17. Carson, E. J.; Pruett, S. B. Development and characterization of a binge drinking model in mice for evaluation of the immunological effects of ethanol Alcohol.: Clin. Exp. Res. 1996, 20, 132-8 10.1111/j.1530-0277.1996.tb01055.x
18. Massey, V. L.; Arteel, G. E. Acute alcohol-induced liver injury Front. Physiol. 2012, 3, 193 10.3389/fphys.2012.00193
19. Kanuri, G.; Weber, S.; Volynets, V.; Spruss, A.; Bischoff, S. C.; Bergheim, I. Cinnamon extract protects against acute alcohol-induced liver steatosis in mice J. Nutr. 2009, 139, 482-7 10.3945/jn.108.100495
20. Lieber, C. S.; DeCarli, L. M.; Sorrell, M. F. Experimental methods of ethanol administration Hepatology 1989, 10, 501-10 10.1002/hep.1840100417
21. Song, Z.; Deaciuc, I.; Song, M.; Lee, D. Y.; Liu, Y.; Ji, X.; McClain, C. Silymarin protects against acute ethanol-induced hepatotoxicity in mice Alcohol.: Clin. Exp. Res. 2006, 30, 407-13 10.1111/j.1530-0277.2006.00063.x
22. Chou, C. H.; Chen, Y. C.; Hsu, M. C.; Tsai, W. L.; Chang, C. Y.; Chiu, C. H. Effect Of Silymarin on Lipid And Alcohol Metabolism In Mice Following Long-Term Alcohol Consumption J. Food Biochem. 2012, 36, 369-377 10.1111/j.1745-4514.2011.00543.x
23. Zuba, D.; Parczewski, A.; Reichenbacher, M. Optimization of solid-phase microextraction conditions for gas chromatographic determination of ethanol and other volatile compounds in blood J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2002, 773, 75-82 10.1016/S1570-0232(02)00143-5
24. Nanji, A. A.; Jokelainen, K.; Lau, G. K. K.; Rahemtulla, A.; Tipoe, G. L.; Polavarapu, R.; Lalani, E. N. Arginine reverses ethanol-induced inflammatory and fibrotic changes in liver despite continued ethanol administration J. Pharmacol. Exp. Ther. 2001, 299, 832-839
25. Li, Y. S.; Wang, J. X.; Jia, M. M.; Liu, M.; Li, X. J.; Tang, H. B. Dragon's blood inhibits chronic inflammatory and neuropathic pain responses by blocking the synthesis and release of substance P in rats J. Pharmacol. Sci. 2012, 118, 43-54 10.1254/jphs.11160FP
26. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J. Protein measurement with the Folin phenol reagent J. Biol. Chem. 1951, 193, 265-75
27. Ding, R. B.; Tian, K.; Huang, L. L.; He, C. W.; Jiang, Y.; Wang, Y. T.; Wan, J. B. Herbal medicines for the prevention of alcoholic liver disease: a review J. Ethnopharmacol. 2012, 144, 457-65 10.1016/j.jep.2012.09.044
28. You, M.; Fischer, M.; Deeg, M. A.; Crabb, D. W. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP) J. Biol. Chem. 2002, 277, 29342-7 10.1074/jbc.M202411200
29. Xiao, J.; Wang, J.; Xing, F.; Han, T.; Jiao, R.; Liong, E. C.; Fung, M. L.; So, K. F.; Tipoe, G. L. Zeaxanthin dipalmitate therapeutically improves hepatic functions in an alcoholic fatty liver disease model through modulating MAPK pathway PLoS One 2014, 9, e95214 10.1371/journal.pone.0095214
30. You, M.; Crabb, D. W. Molecular mechanisms of alcoholic fatty liver: role of sterol regulatory element-binding proteins Alcohol 2004, 34, 39-43 10.1016/j.alcohol.2004.07.004
31. Kahn, B. B.; Alquier, T.; Carling, D.; Hardie, D. G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism Cell Metab. 2005, 1, 15-25 10.1016/j.cmet.2004.12.003
32. Shearn, C. T.; Smathers, R. L.; Jiang, H.; Orlicky, D. J.; Maclean, K. N.; Petersen, D. R. Increased dietary fat contributes to dysregulation of the LKB1/AMPK pathway and increased damage in a mouse model of early-stage ethanol-mediated steatosis J. Nutr. Biochem. 2013, 24, 1436-45 10.1016/j.jnutbio.2012.12.002
33. Everitt, H.; Hu, M.; Ajmo, J. M.; Rogers, C. Q.; Liang, X.; Zhang, R.; Yin, H.; Choi, A.; Bennett, E. S.; You, M. Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice Am. J. Physiol. Gastrointest. Liver Physiol. 2013, 304, G38-47 10.1152/ajpgi.00309.2012
34. Shen, Z.; Liang, X.; Rogers, C. Q.; Rideout, D.; You, M. Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298, G364-74 10.1152/ajpgi.00456.2009
35. Garcia-Villafranca, J.; Guillen, A.; Castro, J. Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver Biochimie 2008, 90, 460-6 10.1016/j.biochi.2007.09.019
36. Shearn, C. T.; Backos, D. S.; Orlicky, D. J.; Smathers-McCullough, R. L.; Petersen, D. R. Identification of 5′ AMP-activated kinase as a target of reactive aldehydes during chronic ingestion of high concentrations of ethanol J. Biol. Chem. 2014, 289, 15449-62 10.1074/jbc.M113.543942
37. Meng, S.; Cao, J.; Feng, Q.; Peng, J.; Hu, Y. Roles of Chlorogenic Acid on regulating glucose and lipids metabolism: a review Evid. Based Complement. Alternat. Med. 2013, 2013, 801457 10.1155/2013/801457
38. Mubarak, A.; Hodgson, J. M.; Considine, M. J.; Croft, K. D.; Matthews, V. B. Correction to Supplementation of a high-fat diet with chlorogenic acid is associated with insulin resistance and hepatic lipid accumulation in mice J. Agric. Food Chem. 2015, 63, 1882 10.1021/acs.jafc.5b00621
39. Feng, R. T. The chemopreventive activity of chlorogenic acid is mediated by inhibiting AP-1-MAPKs pathway and inducing phase II detoxifying enzyme through stimulating Nrf2 signaling Cancer Epidem. Biomar. 2004, 13, 1880s
40. Ji, L.; Jiang, P.; Lu, B.; Sheng, Y.; Wang, X.; Wang, Z. Chlorogenic acid, a dietary polyphenol, protects acetaminophen-induced liver injury and its mechanism J. Nutr. Biochem. 2013, 24, 1911-9 10.1016/j.jnutbio.2013.05.007
41. Brownsey, R. W.; Boone, A. N.; Elliott, J. E.; Kulpa, J. E.; Lee, W. M. Regulation of acetyl-CoA carboxylase Biochem. Soc. Trans. 2006, 34, 223-7 10.1042/BST20060223
42. Kawaratani, H.; Tsujimoto, T.; Douhara, A.; Takaya, H.; Moriya, K.; Namisaki, T.; Noguchi, R.; Yoshiji, H.; Fujimoto, M.; Fukui, H. The effect of inflammatory cytokines in alcoholic liver disease Mediators Inflammation 2013, 2013, 495156 10.1155/2013/495156
43. Wu, D.; Cederbaum, A. I. Oxidative stress and alcoholic liver disease Semin. Liver Dis. 2009, 29, 141-54 10.1055/s-0029-1214370